Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Antibiotic resistance poses one of the most urgent challenges to public health worldwide. During this process, bacteria acquire genetic mutations that help them to become resistant to antibiotics.

Petri dish © Adobe Stock

If bacteria become completely resistant to all antibiotics, this treatment will effectively become useless, and simple infections could cause deaths. In fact, this problem is already causing an estimated 1.3 million deaths every year.

One of the biggest challenges is that current testing methods can take up to two days to determine the most effective antibiotic for an infection. The goal of the Oxford Martin Programme on Antimicrobial Resistance Testing was to create a test that detects whether a patient’s bacteria are resistant to antibiotics within an hour. The test works by taking images of a patient’s bacteria under a microscope and using artificial intelligence (AI) to look for any changes that occur when antibiotics are applied to these samples. We recently published results from our citizen science project that investigated what makes some of these bacteria harder for AI to classify.

We collected thousands of images of resistant and sensitive bacteria treated with antibiotics. Bacteria that are sensitive to an antibiotic treatment develop changes to their shape, DNA, and cell wall. The AI model learns to detect these changes by studying images of bacteria that have responded to the antibiotic treatment and images of bacteria that don’t.

Sometimes, even though our AI model has seen thousands of images of antibiotic-treated bacteria, it still makes mistakes. In a recent research paper, we showed that our current model is about 80% accurate at classifying each Escherichia coli (E. coli) cell. Although this leads to very high confidence when determining whether a whole sample is antibiotic sensitive or resistant, we want our diagnostic test to be as robust as possible.

We noticed that there was some variation in the extent to which E. coli cells changed after the antibiotic treatment, even when they were treated with the same concentration of antibiotic and had the same level of antibiotic resistance. In some cases, cells that looked like a resistant cell were actually sensitive, and vice versa. We started the Infection Inspection project to see which bacterial cells were most likely to be misinterpreted by volunteers, so that we could learn what features might also confuse the AI model. Then, we could focus on understanding those types of cells in our future research. We were also curious whether humans could detect more nuanced features than the AI model.

Volunteers were shown a picture of an E. coli cell that we treated with the antibiotic ciprofloxacin, stained, and imaged with our microscope. Because we grew the E. coli from strains collected at the hospital microbiology laboratory, we knew which strains were sensitive or resistant to ciprofloxacin on standard tests. Equipped with the field guide, volunteers could classify each image as resistant, sensitive, or an image processing error.

Read the full story on the Oxford Martin School website.

 

 

Similar stories

New Nature Health commentary calls for solidarity in a more transactional global health era

As geopolitical interests drive a more transactional global health era, a new Nature Health commentary argues for solidarity to guide how resources are shared, decisions are made and health equity is advanced.

Building sustainable breastfeeding support systems beyond hospital care

Research led by Dr Martha Mwangome at the KEMRI-Wellcome Research Programme is strengthening breastfeeding support for malnourished infants after hospital discharge, extending care into communities with the aim of improving exclusive breastfeeding, infant growth, neurodevelopment and recovery.

Behind the Title - Becoming an Oxford Professor: Featuring Professor Sassy Molyneux

Professor Sassy Molyneux reflects on her unconventional path to becoming an Oxford Professor of Global Health, shaped by 26 years living and working in Kenya and an interdisciplinary career spanning health systems, social science and research ethics.

Oxford researchers support international response to Bundibugyo virus disease outbreak

Teams from across the University of Oxford are supporting the international response to the current Bundibugyo virus disease outbreak through interdisciplinary research spanning biomedical, public health and social and behavioural science.

Unlocking the full potential of community health workers for Africa’s adolescents

New study identifies opportunities to strengthen adolescent health and well-being in Africa.

Smoking and drinking exacerbate social inequalities in premature deaths in India

Study finds social inequality is a major predictor of premature death, even among people who neither smoke nor drink alcohol.